- Home
- GOVX vs XELB Comparison
GOVX vs XELB Comparison
Compare GOVX & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- XELB
- Stock Information
- Founded
- GOVX 2001
- XELB 2011
- Country
- GOVX United States
- XELB United States
- Employees
- GOVX N/A
- XELB N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- XELB Multi-Sector Companies
- Sector
- GOVX Health Care
- XELB Miscellaneous
- Exchange
- GOVX Nasdaq
- XELB Nasdaq
- Market Cap
- GOVX 15.1M
- XELB 4.6M
- IPO Year
- GOVX N/A
- XELB N/A
- Fundamental
- Price
- GOVX $0.50
- XELB $1.52
- Analyst Decision
- GOVX Strong Buy
- XELB
- Analyst Count
- GOVX 5
- XELB 0
- Target Price
- GOVX $12.40
- XELB N/A
- AVG Volume (30 Days)
- GOVX 2.6M
- XELB 100.6K
- Earning Date
- GOVX 08-05-2025
- XELB 08-13-2025
- Dividend Yield
- GOVX N/A
- XELB N/A
- EPS Growth
- GOVX N/A
- XELB N/A
- EPS
- GOVX N/A
- XELB N/A
- Revenue
- GOVX $5,591,576.00
- XELB $7,407,000.00
- Revenue This Year
- GOVX N/A
- XELB $23.96
- Revenue Next Year
- GOVX N/A
- XELB $53.02
- P/E Ratio
- GOVX N/A
- XELB N/A
- Revenue Growth
- GOVX N/A
- XELB N/A
- 52 Week Low
- GOVX $0.43
- XELB $1.51
- 52 Week High
- GOVX $11.18
- XELB $8.49
- Technical
- Relative Strength Index (RSI)
- GOVX 29.07
- XELB 31.72
- Support Level
- GOVX $0.43
- XELB $1.73
- Resistance Level
- GOVX $0.98
- XELB $2.00
- Average True Range (ATR)
- GOVX 0.14
- XELB 0.17
- MACD
- GOVX -0.06
- XELB 0.01
- Stochastic Oscillator
- GOVX 5.21
- XELB 3.63
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About XELB Xcel Brands Inc.
Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.